Yifei Cheng - Concepedia

Author

Yifei Cheng

Peking University ORCID

Also Known As

Cheng Yifei, Y Cheng, Y F Cheng, Yi-Fei Cheng, Yi-fei Cheng, Yifei Cheng, Yi‐Fei Cheng, Yi‐fei Cheng, cheng yifei

162

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Peking University Peking University People's Hospital Center for Life Sciences Chinese Academy of Medical Sciences & Peking Union Medical College Shenzhen Genoimmune Medical Institute

About

Yifei Cheng is an author at Peking University specializing in transplantation, hematology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	419
2	Health Sciences	8	8	276
3	Engineering	2	2	42
4	Natural Sciences	1	1	20
5	Allergy	1	1	16

Yifei Cheng

Publications

945

Citations

H-Index

Page 1

	Year	Citations
Donor‐derived<scp>CD</scp>19‐targeted T cell infusion induces minimal residual disease‐negative remission in relapsed B‐cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation Yu‐Hong Chen, Yifei Cheng, Pan Suo, British Journal of Haematology Cell TherapyImmunologyTransplantation MedicineCell Replacement TherapyT Cells	2017	102
Incidence, Risk Factors, Microbiology and Outcomes of Pre-engraftment Bloodstream Infection After Haploidentical Hematopoietic Stem Cell Transplantation and Comparison With HLA-identical Sibling Transplantation Chen‐Hua Yan, Yu Wang, Xiao‐Dong Mo, Clinical Infectious Diseases	2018	67
Long-term follow-up of CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation Yu‐Hong Chen, Xian Zhang, Yifei Cheng, Cytotherapy Cell TherapyTransplantationMarrow TransplantationLong-term Follow-upStem Cell Transplantation	2020	42
First‐line choice for severe aplastic anemia in children: Transplantation from a haploidentical donor vs immunosuppressive therapy Yifei Cheng, Zhengli Xu, Yuanyuan Zhang, Clinical Transplantation	2017	41
Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era Yu‐juan Xue, Yifei Cheng, Aidong Lu, Biology of Blood and Marrow Transplantation	2018	40
Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study Lan‐Ping Xu, Shunqing Wang, Yanru Ma, Journal of Hematology & Oncology	2019	38
Unmanipulated haploidentical hematopoietic stem cell transplantation is an excellent option for children and young adult relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after CAR-T-cell therapy Guan-Hua Hu, Xiang‐Yu Zhao, Ying‐xi Zuo, Leukemia Hematological MalignancyCell TherapyTransplantationMarrow TransplantationMixed-phenotype Acute Leukemia	2021	33
Basiliximab as Treatment for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Patients after Haploidentical Hematopoietic Stem Cell Transplantation Feifei Tang, Yifei Cheng, Lan‐Ping Xu, Biology of Blood and Marrow Transplantation Gut Sr AgvhdTransplantationMarrow TransplantationBone Marrow FailurePediatric Hematology	2019	32
Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment Guanhua Hu, Yifei Cheng, Aidong Lu, BMC Cancer	2020	32
Stromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma Yifei Cheng, Xiaofang Chen, Feng Li, Cell Discovery	2025	29

Page 1